Status:

TERMINATED

Heart Failure Diagnostic Performance of an Expirogram Analysis Algorithm Evaluating 4 Biomarkers

Lead Sponsor:

University Hospital, Montpellier

Collaborating Sponsors:

Université Montpellier

Conditions:

Heart Failure

Eligibility:

All Genders

25-85 years

Phase:

NA

Brief Summary

Telemonitoring is a key clinical issue in heart failure (HF). Bedside measurement systems using handheld devices provide "digital biomarkers" useful for remote monitoring. A recent systematic review a...

Detailed Description

In the context of chronic diseases and heart failure (HF) in particular, telemedicine and telemonitoring have emerged as major clinical challenges today. The development of point-of-care measurement s...

Eligibility Criteria

Inclusion

  • Age from 25 to 85,
  • Stable or worsening heart failure, diagnosed by a cardiologist,
  • Patients requiring respiratory function tests and cardiac explorations as part of a work-up at Montpellier University Hospital (pre-cardiac transplant, pre-rehabilitation, pre-surgery, etc....).

Exclusion

  • Subject in a period of relative exclusion in relation to another protocol, or for whom the maximum annual indemnity of €6000 has been reached.
  • Adult protected by law (guardianship, curatorship or safeguard of justice)
  • Subject participating in another interventional research protocol
  • Subject not affiliated to a social security scheme or not benefiting from such a scheme.
  • Pregnant or breast-feeding woman, patient unable to give consent, protected adult, vulnerable persons (art.L. 1121-6, L. 1121-7, L. 1211-8, L. 1211-9 of the french legislation).
  • Subject deprived of liberty by judicial or administrative decision
  • Subject having refused to give consent
  • Healthy Volunteers :
  • Age from 25 to 85,
  • Volunteers with no previous cardiorespiratory history or treatment.

Key Trial Info

Start Date :

April 26 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06014593

Start Date

April 26 2024

End Date

October 31 2024

Last Update

February 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Montpellier

Montpellier, France, 34000